Procalcitonin is a biomarker for disease severity rather than bacterial co-infection in COVID-19

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	315
Number of pages	1
Journal	European Journal of Emergency Medicine
Volume	29
Issue number	4
DOIs	https://doi.org/10.1097/MEJ.0000000000000882
Publication status	Published - 1 Aug 2022
Externally published	Yes

Access to Document

@article{5d720fbe3d85401c9e021768106c228a,

title = "Procalcitonin is a biomarker for disease severity rather than bacterial co-infection in COVID-19",

author = "Heer, \{Randeep S.\} and Mandal, \{Amit K.J.\} and Piotr Szawarski and Missouris, \{Constantinos G.\}",

year = "2022",

month = aug,

day = "1",

doi = "10.1097/MEJ.0000000000000882",

language = "English",

volume = "29",

pages = "315",

journal = "European Journal of Emergency Medicine",

issn = "0969-9546",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Procalcitonin is a biomarker for disease severity rather than bacterial co-infection in COVID-19

AU - Heer, Randeep S.

AU - Mandal, Amit K.J.

AU - Szawarski, Piotr

AU - Missouris, Constantinos G.

PY - 2022/8/1

Y1 - 2022/8/1

UR - https://www.scopus.com/pages/publications/85133673064

U2 - 10.1097/MEJ.0000000000000882

DO - 10.1097/MEJ.0000000000000882

M3 - Letter

C2 - 34560701

AN - SCOPUS:85133673064

SN - 0969-9546

VL - 29

SP - 315

JO - European Journal of Emergency Medicine

JF - European Journal of Emergency Medicine

IS - 4

ER -